Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Smigan, L.
and
Perris, C.
1984.
Current Trends in Lithium and Rubidium Therapy.
p.
111.
Johnson, Gordon
1984.
Lithium*.
Medical Journal of Australia,
Vol. 141,
Issue. 9,
p.
595.
Schou, M.
1985.
Vol. 9,
Issue. ,
p.
27.
Calev, Avraham
Korin, Yaacov
Shapira, Baruch
Kugelmass, Sol
and
Lerer, Bernard
1986.
Verbal and non-verbal recall by depressed and euthymic affective patients.
Psychological Medicine,
Vol. 16,
Issue. 4,
p.
789.
CARLSON, GABRIELLE A.
RAPPORT, MARK D.
KELLY, KEVIN L.
and
PATAKI, CAROLY S.
1992.
The Effects of Methylphenidate and Lithium on Attention and Activity Level.
Journal of the American Academy of Child & Adolescent Psychiatry,
Vol. 31,
Issue. 2,
p.
262.
Sweet, Jerry J.
Newman, Peter
and
Bell, Brian
1992.
Significance of depression in clinical neuropsychological assessment.
Clinical Psychology Review,
Vol. 12,
Issue. 1,
p.
21.
Medalia, Alice
and
Gold, James
1992.
Handbook of Neuropsychological Assessment.
p.
457.
Classen, W.
1997.
Die Lithiumtherapie.
p.
118.
Müller-Oerlinghausen, B.
2000.
Does effective lithium prophylaxis result in a symptom-free state of manic-depressive illness? Some thoughts on the fine-tuning of mood stabilization.
Comprehensive Psychiatry,
Vol. 41,
Issue. 2,
p.
26.
Stip, Emmanuel
Dufresne, Jocelyn
Lussier, Isabelle
and
Yatham, Lakshmi
2000.
A double-blind, placebo-controlled study of the effects of lithium on cognition in healthy subjects: mild and selective effects on learning.
Journal of Affective Disorders,
Vol. 60,
Issue. 3,
p.
147.
Zubieta, Jon-Kar
Huguelet, Philippe
O'Neil, Renee Lajiness
and
Giordani, Bruno J.
2001.
Cognitive function in euthymic Bipolar I Disorder.
Psychiatry Research,
Vol. 102,
Issue. 1,
p.
9.
Pachet, Arlin K.
and
Wisniewski, Amy M.
2003.
The effects of lithium on cognition: an updated review.
Psychopharmacology,
Vol. 170,
Issue. 3,
p.
225.
MacQueen, Glenda
and
Young, Trevor
2003.
Cognitive effects of atypical antipsychotics: focus on bipolar spectrum disorders.
Bipolar Disorders,
Vol. 5,
Issue. s2,
p.
53.
Tsaltas, Eleftheria
Kontis, Dimitris
Boulougouris, Vasileios
and
Papadimitriou, George N.
2009.
Lithium and cognitive enhancement: leave it or take it?.
Psychopharmacology,
Vol. 202,
Issue. 1-3,
p.
457.
Rybakowski, Janusz K.
Permoda-Osip, Agnieszka
and
Borkowska, Alina
2009.
Response to prophylactic lithium in bipolar disorder may be associated with a preservation of executive cognitive functions.
European Neuropsychopharmacology,
Vol. 19,
Issue. 11,
p.
791.
Dias, V. V.
Balanzá‐Martinez, V.
Soeiro‐de‐Souza, M. G.
Moreno, R. A.
Figueira, M. L.
Machado‐Vieira, R.
and
Vieta, E.
2012.
Pharmacological approaches in bipolar disorders and the impact on cognition: a critical overview.
Acta Psychiatrica Scandinavica,
Vol. 126,
Issue. 5,
p.
315.
Malhi, Gin S.
Tanious, Michelle
Das, Pritha
Coulston, Carissa M.
and
Berk, Michael
2013.
Potential Mechanisms of Action of Lithium in Bipolar Disorder.
CNS Drugs,
Vol. 27,
Issue. 2,
p.
135.
Pfennig, Andrea
Alda, Martin
Young, Trevor
MacQueen, Glenda
Rybakowski, Janusz
Suwalska, Aleksandra
Simhandl, Christian
König, Barbara
Hajek, Tomas
O’Donovan, Claire
Wittekind, Dirk
von Quillfeldt, Susanne
Ploch, Jana
Sauer, Cathrin
and
Bauer, Michael
2014.
Prophylactic lithium treatment and cognitive performance in patients with a long history of bipolar illness: no simple answers in complex disease-treatment interplay.
International Journal of Bipolar Disorders,
Vol. 2,
Issue. 1,
King, Margaret K.
Pardo, Marta
Cheng, Yuyan
Downey, Kimberlee
Jope, Richard S.
and
Beurel, Eléonore
2014.
Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments.
Pharmacology & Therapeutics,
Vol. 141,
Issue. 1,
p.
1.
Vreeker, Annabel
van Bergen, Annet H.
and
Kahn, René S.
2015.
Cognitive enhancing agents in schizophrenia and bipolar disorder.
European Neuropsychopharmacology,
Vol. 25,
Issue. 7,
p.
969.